HP

Heman Pruthi

Active Director Director DIN 06599740
DIN 06599740 First appointment Apr 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Apr 2013
Shareholding value •••• Premium profile

About Heman Pruthi

Data last updated:

Heman Pruthi is a Director at Kash Medicare Private Limited (since 2013), Additional Director at Elder Neutraciticals Private Limited (since 2025) and Director at Kash Logistics Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹184 Cr; the largest is Kash Medicare Private Limited at ₹163 Cr (FY 2025). Earlier, Heman Pruthi was a Director at Nova Softech Private Limited (2015–2016) and Director at Elder Remedies Limited (2019–2021).

DIN 06599740
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2013
Oldest Company Age 44 yrs
Largest company Kash Medicare Private Limited · ₹163 Cr (FY 2025)
Combined revenue ₹184 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kash Medicare Private Limited U51909DL2008PTC183790
Director01 Apr 20132008₹163 Cr (FY 2025)Active
Elder Neutraciticals Private Limited U15400MH2015PTC261070
Additional Director19 Feb 20252015₹10.68 Cr (FY 2021)Active
Kash Logistics Private Limited U93030DL1982PTC014191
Director20 Apr 20211982₹10.02 Cr (FY 2024)Active
Kash Estates Llp AAU-5825
Designated Partner06 Nov 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nova Softech Private Limited U74999DL2004PTC124048
Director23 Jan 20152004₹8.21 Cr (FY 2025)Active
Elder Remedies Limited U24232DL2012PLC243076
Director05 Jun 20192012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kash Estates Llp
Kash Medicare Private Limited
Kash Logistics Private Limited
Elder Neutraciticals Private Limited
Premium access

Shareholding and investment profile for Heman Pruthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Heman Pruthi

Heman Pruthi currently holds 4 directorships: Kash Medicare Private Limited (Director, since 01 Apr 2013, revenue ₹163 Cr (FY 2025)); Elder Neutraciticals Private Limited (Additional Director, since 19 Feb 2025, revenue ₹10.68 Cr (FY 2021)); Kash Logistics Private Limited (Director, since 20 Apr 2021, revenue ₹10.02 Cr (FY 2024)); Kash Estates Llp (Designated Partner, since 06 Nov 2020).

Heman Pruthi was first appointed on 01 Apr 2013 as Director at Kash Medicare Private Limited. The most recent appointment on record is 19 Feb 2025 at Elder Neutraciticals Private Limited.

The 3 current companies of Heman Pruthi that report revenue have a combined latest revenue of ₹184 Cr: Kash Medicare Private Limited ₹163 Cr (FY 2025); Elder Neutraciticals Private Limited ₹10.68 Cr (FY 2021); Kash Logistics Private Limited ₹10.02 Cr (FY 2024).

Heman Pruthi held 2 earlier board appointments: Nova Softech Private Limited (Director, 23 Jan 2015 to 30 Nov 2016); Elder Remedies Limited (Director, 05 Jun 2019 to 16 Dec 2021).

The current boards of Heman Pruthi's companies include Akhil Pruthi (Kash Medicare Private Limited), Ariduman Kumar Jain (Kash Medicare Private Limited), Ashish Jain (Kash Medicare Private Limited), Kapil Pruthi (Kash Medicare Private Limited), Kunal Pruthi (Kash Medicare Private Limited), Rahul Jain (Kash Medicare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available